Impact of US custom policies on the chemical & pharmaceutical industry

USA launches Section 232 investigation into pharmaceuticals

Strengthening free trade, dismantling customs duties

Rejecting the ‘No to a 10-Million Switzerland’ Initiative

Overview and position on relations with the EU

‘Switzerland seems less “hungry” for competition’

Life Sciences: Switzerland must become more active

Full association with Horizon – why EU research ties matter to CH

Full association to Horizon Europe essential

EU chemicals legislation: Switzerland's pragmatic responses

Differentiated view of "risk versus hazard"

TFA: key facts at a glance

Overview and position on chemicals regulation

The poison and the dose – Great panic over small values?

PFAS: Key facts at a glance